This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Mavridou, D., Gornall, R., Campbell, I. et al. TP53 intron 6 polymorphism and the risk of ovarian and breast cancer. Br J Cancer 77, 676–677 (1998). https://doi.org/10.1038/bjc.1998.108
Issue Date:
DOI: https://doi.org/10.1038/bjc.1998.108
- Springer Nature Limited
This article is cited by
-
Epistatic interaction of Arg72Pro TP53 and −710 C/T VEGFR1 polymorphisms in breast cancer: predisposition and survival
Molecular and Cellular Biochemistry (2013)
-
Mutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B
BMC Cancer (2005)
-
Mutation and homozygous deletion analyses of genes that control the G1/S transition of the cell cycle in skin melanoma: p53, p21, p16 and p15
Clinical and Translational Oncology (2005)
-
Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations
British Journal of Cancer (1999)